Analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Performance
Shares of MTEX opened at $11.00 on Friday. Mannatech has a 52-week low of $6.75 and a 52-week high of $13.00. The firm has a market capitalization of $20.74 million, a PE ratio of -13.58 and a beta of 1.18. The firm has a 50-day moving average price of $9.23 and a 200 day moving average price of $8.03. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The company had revenue of $31.73 million for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Articles
- Five stocks we like better than Mannatech
- What is a Dividend King?
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Breakout Stocks: What They Are and How to Identify Them
- How AI Implementation Could Help MongoDB Roar Back in 2025
- What Are Some of the Best Large-Cap Stocks to Buy?
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
